Member Info for alkin

I have doubled up, Activ-2 is the promised land

Where there is war there is an opportunity.
I was listening yesterday and based on election status for a few large EU partners and the winter Olympics being over (China would have been pis*ed) the timing of this incursion was timed to perfection.

Dr.A surely a conversation of an existing incinerator would be the quickest route to market?
I see Lavo are keen to try their hydrogen storage, maybe get them involved as well?

Sounds like 007 is in on the action (kill order)
Panic selling causes low price but even after that it would have increased if the buyers were there.
Polygon are preparing for Activ-2 and then they will go over 30%

Size82 - Synairgen's focus has long been the USA, hence the first jobs advertised. I am not saying Sprinter results wouldn't have been a good thing, what I am saying is that the ultimate prize and why Polygon got involved was Activ2. Sprinter not performing has given them a significant buying opportunity at a reduced prize and they will get to 29.9% quick sticks...
Not sure how the 30% works but guess they could buy 10% in 1 day if they wanted to jump quickly from 29.9% to 39.9%???

There is an opportunity here but in the near term the Baltic states will be wanting NATO to sure up their defences.
Historically, Russia lost millions of troops helping Europe overcome Germany, this war makes no sense and will only lead to more death and destruction when we should be focusing on a green economy.
This will however, push western nations to remove dependencies on Russia for Oil and Gas but we really need OPEC to step up now and lower the price of oil before the West goes broke!
In the short term, get onto your council's we know you can mix 20% hydrogen with gas and most councils have incinerators that could be switched out to use DMG's and produce hydrogen!

With Russia invading the Ukraine and Synairgen releases poor Sprinter results, its not been a good week. That said Polygon's investment are providing a ray of hope and we need to cling on to that!
I'm pretty sure Polygon did their homework before investing so much and although positive Sprinter results would have been great, Activ-2 P3 positive results have always been the end game.
Fellow investors, hold on tight as the roller-coaster ride has only just begun!

Basically Polygon are a bit more astute than your average investor.
Most smaller holder saw the failure of the Sprinter trial as a reason to dump their shares, whereas Polygon read the detail and have considered that the reason behind the change in P2 vs P3 was the fact that other drugs were administered. This is not the case with Activ-2.
So you either believe Synairgen that this is why Sprinter didn't live up to expectations or you dump and run.
I have added...

If Polygon take a 30%+ stake they will have to make an offer based on £2+ but based on where we are they should be able to buy another 20% at these prices and then the rest is fair game.
Most probable outcome is that they hover around 29% until Activ-2 news

You sure its not just a placebo?

At these prices Polygon would be foolhardy not to accumulate up to 29.9%. However, I believe they could then buy loads more and end up closer to 40-50% and then make a TR-1.
The value was always in Activ-2 not the Sprinter trial...

Reckon Polygon will hold at 29.99% so they don't have to make a formal bid until Activ-2 is in.
Either that or they will have a really big push at these low prices and get to a much higher percentage and then make a bid (so paying out to less shareholders)

The Takeover Panel
When a person or group acquires interests in shares carrying 30% or more of the voting rights of a company, they must make a cash offer to all other shareholders at the highest price paid in the 12 months before the offer was announced (30% of the voting rights of a company is treated by the Code as the level at which effective control is obtained).
https://www.thetakeoverpanel.org.uk/the-code/download-code

Polygon will have analysed the data and comments from Synairgen and concluded that if it truly was the drugs administered in the hospitals that led to SNG being less effective, then this is a none issue for Activ-2 as this was pre-hospitalisation.
At 30% Polygon have to make an offer for the company so watch the SP increase (they are now buying very cheaply)

If Polygon get 30% they will probably make an offer close the share price

Welcome, I think everyone is waiting for the CEO's vision.
Once the first plant is operational or LINDE get the EU transition grant, you will see the share price rocket, although Russia invading the Ukraine won't help.

Hold on until Activ-2 P3 results, these should be better due to being pre-hospitalisation

Tried to buy some shares this morning on AJ Bell, can't buy or sell

Sorry mcadder the only positive news now will be Activ-2 P3 results

Great post, I think a key element here is that the introduction of other drugs affected the outcome and the hope will be that the Activ-2 trial will not be effected in the same way. I think it is important to note as well that Merck got EUA from the FDA based on 30% effectiveness